BBSRC Portfolio Analyser
Award details
Antiviral therapies for honeybees
Reference
BB/M013685/1
Principal Investigator / Supervisor
Professor David Evans
Co-Investigators /
Co-Supervisors
Institution
University of St Andrews
Department
Biology
Funding type
Research
Value (£)
165,588
Status
Completed
Type
Research Grant
Start date
01/08/2015
End date
06/06/2017
Duration
22 months
Abstract
unavailable
Summary
Honeybees are the most important managed pollinating insects, contributing 'services' worth billions of dollars to global agriculture, as well as producing honey. Healthy colonies are essential for pollination and honey production. Honeybee health is threatened by viruses transmitted by the ectoparasitic mite Varroa when it feeds on bee haemolymph (blood). The most important virus is deformed wing virus (DWV). In the absence of Varroa the virus is present at low levels, is genetically diverse and causes minimal impact on colony health. When transmitted by Varroa, a single virulent variant (which we term DWVv) replicates to 10,000 times higher levels, causing serious developmental disease to young bees and reducing the lifespan of adults, so accounting for the 20%+ colony losses over winter. We have identified DWVv and propose to look at its global distribution and test therapies designed to inhibit virus replication. These studies are critical too improve honeybee health.
Committee
Not funded via Committee
Research Topics
Animal Health, Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund (FOF) [2004-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search